No shortage on file

MINT-GABAPENTIN

MINT PHARMACEUTICALS INC

Quick answers

Is there a shortage of MINT-GABAPENTIN in Canada?

No. There is no current shortage of MINT-GABAPENTIN 300MG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy

StatusNo shortage on file

Same-ingredient products on fileNone found

Checked by MedShort2026-11-12

DIN

02408899

Strength

300MG

Dosage Form

CAPSULE

Route

ORAL

Active Ingredient

GABAPENTIN

See all GABAPENTIN products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

2026-06-12

Resolved

Requirements related to complying with good manufacturing practices.

Other Products from MINT PHARMACEUTICALS INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

300MG · DIN 02480956

25MG · DIN 02468859

10MG · DIN 02468840

400MG · DIN 02524716

800MG · DIN 02524724

200MG · DIN 02524708

70.0MG · DIN 02394871

5MG · DIN 02362651

10MG · DIN 02362678

1MG · DIN 02393573

5MG · DIN 02495449

2.5MG · DIN 02495430